(Q36319026)

13 August 2017

Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. (English)

1 reference

13 August 2017

1 reference

1 reference

Pietz K

1

1 reference

13 August 2017

Hagell P

series ordinal

2

1 reference

13 August 2017

Odin P

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

13 August 2017

1 reference

13 August 2017

65

1 reference

13 August 2017

5

1 reference

13 August 2017

709-716

1 reference

Apomorphine in Parkinson's disease

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Usefulness of pallidotomy in advanced Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Perioperative problems in Parkinson's disease and their management: apomorphine with rectal domperidone

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Pharmacokinetics of apomorphine in Parkinson's disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Dopamine agonists in Parkinson's disease: a look at apomorphine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Motor response to apomorphine and levodopa in asymmetric Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Subcutaneous apomorphine infusion in Parkinson's disease: does it have a role?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Drug treatment of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Apomorphine in patients with Parkinson's disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Apomorphine for motor fluctuations and freezing in Parkinson's disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Subcutaneous apomorphine in the treatment of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Efficacy of sublingual apomorphine in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Comparison of motor response to apomorphine and levodopa in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Core assessment program for intracerebral transplantations (CAPIT)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Intranasal apomorphine: a new treatment in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Intranasal apomorphine rescue therapy for parkinsonian "off" periods.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Subcutaneous apomorphine in Parkinson's disease

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Intranasal apomorphine in Parkinson's disease

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Clinical usefulness of apomorphine in movement disorders.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170363

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

22 September 2018

1 reference

12 December 2020

External and implanted pumps for apomorphine infusion in parkinsonism

1 reference

12 December 2020

Apomorphine infusion for motor fluctuations in Parkinson's disease

1 reference

12 December 2020

SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONS

1 reference

12 December 2020

Subcutaneous apomorphine for on-off oscillations in Parkinson's disease

1 reference

12 December 2020

Peripheral pharmacokinetics of apomorphine in humans

1 reference

12 December 2020

Rectal apomorphine in Parkinson's disease

1 reference

12 December 2020

Apomorphine and diphasic dyskinesia

1 reference

12 December 2020

Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans

1 reference

12 December 2020

Apomorphine infusional therapy in Parkinson's disease: clinical utility and lack of tolerance

1 reference

12 December 2020

Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories

1 reference

12 December 2020

Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?

1 reference

12 December 2020

Absorption of apomorphine by various routes in parkinsonism

1 reference

12 December 2020

Intermittent subcutaneous apomorphine injection treatment for parkinsonian motor oscillations

1 reference

12 December 2020

The clinical use of apomorphine in Parkinson's disease

1 reference

12 December 2020

Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years

1 reference

12 December 2020

[Long-term results of continuous subcutaneous apomorphine pump therapy in patients with advanced Parkinson disease]

1 reference

12 December 2020

Pharmacokinetics of apomorphine in parkinsonian patients

1 reference

12 December 2020

Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.65.5.709

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

9810943

1 reference